Bipolar Disorder With Alcoholism in Han Chinese
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01188395|
Recruitment Status : Unknown
Verified August 2010 by National Cheng-Kung University Hospital.
Recruitment status was: Recruiting
First Posted : August 25, 2010
Last Update Posted : August 25, 2010
|Condition or disease|
From family, twin and adoption studies supported a strong hereditary component in unsubtyped alcohol dependency (Cloninger et al., 1981; Reich et al., 1999; Huang et al., 2004). Dopamine, serotonin related genes and ADH, ALDH genes have been considered as candidate genes for alcohol dependency (Goldman, 1995; Reich et al., 1999; Noble et al., 2000). However, both in simple or family-base association studies have generated controversy about the relationship between candidate genes and alcoholism (Edenberg et al., 1998; Reich et al., 1999; Noble et al., 2000). One of the possible explanations may be due to that those studies did not subtype alcohol dependency, even though alcoholism is a complex phenotype with a heterogeneous etiology (Huang et al., 2004; Lu et al., 2005a).
Our previous research results had already categorized AD among Han Chinese in Taiwan into four subtypes, pure alcoholism (Pure ALC), anxiety-depression alcoholism (ANX/DEP ALC), antisocial alcoholism (Antisocial ALC) and mixed type alcoholism (Mixed ALC) （Huang et al., 2004; Lu et al., 2005; Wang et al., 2007）. Except for Mixed ALC, we have established fundamental genetic validity, and confirmed several candidate genes including MAOA、ADH、ALDH、DRD2.
Mixed ALC is categorized by alcoholism comorbid with other psychiatric disorders including schizophrenia and bipolar disorder. Among them all, bipolar disorders most frequently comorbid with alcohol and substance dependence. The high comorbidity between alcohol dependence among patients with bipolar disorder worsens the treatment effect and prognosis. Bipolar disorders are divided into several categories, including bipolar I disorder (BP-I), bipolar II disorder (BP-II), and cyclothymic disorder. Previous literatures have documented that BP-I and BP-II might have different etiology, phenomenology, characteristics and neuropsychiatric functional impairments in the course of the illness (APA, 1994).
The aim of this study is to explore relation between the comorbidity of different bipolar disorders with alcoholism and neuropsychiatric function and candidate genes. We plan to establish genetic validity for this subtype of alcoholism. In addition, by comparing this subtyped alcoholism to normal control, we plan to examine the genetic validity of such comorbidity. We plan to find specific clinical characteristic from neuropsychiatric aspects of such subtype for future early diagnosis, prediction and prevention.
|Study Type :||Observational|
|Estimated Enrollment :||105 participants|
|Observational Model:||Ecologic or Community|
|Study Start Date :||August 2009|
|Estimated Primary Completion Date :||July 2012|
|Estimated Study Completion Date :||July 2012|
subtypes of bipolar disorders
Bipolar I Disorder with alcoholism Bipolar I Disorder without alcoholism Bipolar II Disorder with alcoholism Bipolar II Disorder without alcoholism
- Young's Mania Rating Scale (YMRS) [ Time Frame: baseline, 3 months ]The severity of manic symptoms of patients will be rated by using YMRS.
- Hamilton Depression Rating Scale (HDRS) [ Time Frame: baseline, 3 months ]The severity of depressive symptoms of patients will be measured using HDRS.
- blood sample [ Time Frame: baseline, 3 months ]PCR lab methodology
- DNA [ Time Frame: baseline ]DRD2 TaqI-A PCR-RFLP ADH2 and ALDH2 PCR-RFLP MAO A genotypes
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01188395
|Contact: Ru-Band Lu, MD||+886-6-2353535 ext firstname.lastname@example.org|
|Tainan, Taiwan, 704|
|Contact: Ru-Band Lu, MD +886-6-2353535 ext 5108 email@example.com|
|Principal Investigator: Ru-Band Lu, MD|
|Principal Investigator:||Ru-Band Lu, MD||National Cheng-Kung University Hospital|